C
VRTX icon

Certuity’s Vertex Pharmaceuticals VRTX Stock Holding History

Certuity’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,000
Closed -$219K – 228
2019
Q4 		$219K Buy
+1,000
New +$202K 0.1% 153

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

Certuity's VRTX Position: Q2 2026 in Review

Certuity increased its Vertex Pharmaceuticals (VRTX) stake by 26% in Q2 2026, buying an estimated $674K and bringing the position to 7,449 shares worth $3.7M. The position accounts for 0.18% of the portfolio, ranked #71.

Certuity first reported a position in VRTX in Q4 2019 and has held it in 23 quarters since. 650 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Certuity held 7,449 shares of Vertex Pharmaceuticals worth $3.7M as of Q2 2026.
  • Certuity bought 1,520 Vertex Pharmaceuticals shares in Q2 2026, an estimated $674K.
  • Vertex Pharmaceuticals made up 0.18% of Certuity's portfolio in Q2 2026, its #71 holding.
  • Certuity first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 23 quarters since.
  • 650 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.